What The Current Research Reveals About Utilizing Amnion/Chorion Allografts For Diabetic Foot Ulcers

Charles M. Zelen, DPM, FACFAS, and Thomas Serena, MD | 1,343 reads | 0 comments | 06/19/2017

Treating Diabetic Foot Ulcers Like An Aggressive Cancer

David G. Armstrong DPM MD PhD | 3,398 reads | 0 comments | 01/01/2016

When we tackle the problem of diabetic foot ulcers, the idea is not just the mortality. The idea is that diabetes is like cancer but we do not tend to treat diabetes like cancer and we should be. We should be communicating and using the same language in terms of morbidity and mortality as we do with cancer. When we look at the data from a new study, the mortality rate is similar to the rate of very aggressive cancer.1

Could Micro-Autografts Have Potential In Healing Diabetic Foot Ulcers?

Wayne J. Caputo, DPM, FACFAS, and George J. Fahoury, DPM, FACFAS | 3,400 reads | 0 comments | 02/22/2016

The goal of wound management is to attain cost effective wound closure to reestablish function.1 This is especially true with lower extremity wounds that are debilitating and often lead to a temporary or permanent disability.

A Closer Look At The Newest Cellular Therapy For Diabetic Foot Ulcers

Barbara Aung DPM | 3,324 reads | 0 comments | 08/24/2016

Until recently, there had not been a new product introduced in the wound care arena that had gone through the Food and Drug Administration (FDA) approval process in several years. The FDA recently announced the approval of the Omnigraft Dermal Regeneration Matrix (Integra LifeSciences) for its new indication in the treatment of diabetic foot ulcers in the outpatient clinical setting.

Does Continuous Diffusion Of Oxygen Have Potential In Chronic Diabetic Foot Ulcers?

Mark Couture, DPM | 3,375 reads | 0 comments | 11/19/2015

Chronic wounds, typically defined as wounds that have not decreased in size by 50 percent after four to six weeks of treatment, are often accompanied by complications including peripheral neuropathy, diabetes, peripheral vascular disease (PVD) and poor patient adherence.1-4

Emphasizing Prevention Strategies To Reduce The Economic Burden Of Diabetic Foot Complications

David G. Armstrong DPM MD PhD | 2,274 reads | 0 comments | 03/23/2016

Diabetic foot ulcers cost over $15 billion a year in the United States and a recent study seeks some solutions to relieve the economic burden.1,2

Examining The Potential Of Collagen Powders In The Diabetic Foot

Jonathan Moore, DPM, MS, MA | 12,045 reads | 0 comments | 04/20/2015

Offloading A Diabetic Foot Ulcer In The Developing World

Lakshmi K. Shankhdhar, MD, PGDND, DMRE, MAMS, FICN, FHMI (Boston), Kshitij Shankhdhar, MBBS, Dip Diab, MD, FICN, FAPWCA (USA), Uma Shankhdhar, MBBS, DND, DDM, and Smita Shankhdhar, MBBS, MUPMA, MICN | 5,387 reads | 0 comments | 09/23/2015

At one point, limb loss due to diabetes occurred every 30 seconds. Recent research has reduced the figure to every 20 seconds.1-3 Eighty-five percent of lower limb amputations follow incidence of a diabetic foot ulcer and most are preventable.4,5

A Closer Look At The Potential Of Placental Membrane Grafts For Chronic Diabetic Foot Ulcerations

Sarah Abshier, DPM, CWS | 9,909 reads | 0 comments | 10/23/2015

The treatment of chronic diabetic foot ulcers is a challenging endeavor. Fortunately, medical advances continue to provide promising new technologies to aid physicians in healing difficult wounds. The properties and composition of placental membranes make them a very powerful tool in wound care as placental membranes address the unique myriad needs of chronic diabetic foot ulcers (DFUs).

Keeping Patients With Diabetic Foot Ulcers In Remission

David G. Armstrong DPM MD PhD | 3,774 reads | 1 comments | 11/14/2014

The presence of a diabetic foot ulcer (DFU) often leads to re-ulceration. A new study in the International Journal of Lower Extremity Wounds notes that the complication of DFUs will require more healthcare resources and also reaffirms the importance of podiatric physicians in keeping patients with ulcers in remission.1